Progressive Huntington's disease with neuropsychiatric predominance across fragmented care settings

Gregory Michael Tomlinson1, Manan Gupta2,3,4

  • 1Osteopathic Medicine, University of the Incarnate Word School of Osteopathic Medicine, San Antonio, Texas, USA gtomlins@student.uiwtx.edu.

BMJ Case Reports
|June 23, 2026
PubMed

Insights

This case study shows how Huntington's disease (HD) can progress from psychiatric symptoms to severe motor impairment. Continuous specialist care is crucial for managing this neurodegenerative disorder.

Area of Science:

  • Neurology
  • Neuroscience
  • Psychiatry

Background:

  • Huntington's disease (HD) presents with motor and neuropsychiatric symptoms, but early stages may feature prominent psychiatric issues.
  • A case of a man in his 50s with diagnosed HD and family history illustrates this presentation.

Purpose of the Study:

  • To describe the clinical evolution of Huntington's disease from neuropsychiatric-predominant symptoms to advanced motor deficits.
  • To emphasize the importance of consistent neurological care in managing progressive neurodegenerative diseases.

Main Methods:

  • Longitudinal case observation and serial neurological examinations.
  • Assessment of motor function, cognitive status (set-shifting, verbal fluency), and psychiatric manifestations.
  • Documentation of disease progression within the context of fragmented healthcare access.

Main Results:

  • The patient initially presented with severe psychiatric symptoms (psychosis, suicide attempt) and minimal motor findings.
  • Over time, clear motor progression occurred, including gait abnormalities, weakness, choreiform movements, and wheelchair dependence.
  • Cognitive deficits, including impaired set-shifting and reduced verbal fluency, were consistent with the HD phenotype.

Conclusions:

  • Huntington's disease can evolve from a neuropsychiatric-dominant presentation to significant motor impairment.
  • Fragmented continuity of neurologic care can complicate management and potentially impact disease progression.
  • Longitudinal specialist follow-up is essential for effective management of progressive neurodegenerative conditions like HD.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...